Nectar Lifesciences Limited

Nectar Lifesciences Limited

Nectar Lifesciences Limited has announced the 31st Annual General Meeting (AGM) of the shareholders, scheduled to be held on September 18, 2026, through video conference. The company has sent a letter to shareholders who have not registered their email addresses, providing a web-link to the Annual Report 2025-26. The AGM Notice and Annual Report are also available on the company's website and on the websites of the stock exchanges where the equity shares are listed.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has published a notice of its 31st Annual General Meeting (AGM), e-voting, book closure, and other information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2026.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has published a notice to shareholders regarding its 31st Annual General Meeting (AGM) to be held on September 18, 2026, through video conferencing or other audio-visual means. The notice has been published in Business Standard and Desh Sewak newspapers.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has published its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 464.70 lakhs and a total comprehensive income of Rs. 2,361.20 lakhs.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange about a change in its corporate office from Plot No. 110, Industrial Area, Phase 1, Chandigarh 160 002 to "Godrej Eternia," West Wing (Tower A), Plot No. 70, Industrial Area, Phase-1, Chandigarh, 160 002, effective from September 15, 2026.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has announced the record date for its 31st Annual General Meeting (AGM) as September 11, 2026, for ascertaining the eligibility of members for remote e-voting and/or polling/e-voting.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has announced the outcome of its board meeting, where it has approved the appointment of Dr. Gunmala Suri as an Additional Director, re-appointment of Mr. Sanjiv Goyal, and reconstitution of the Audit Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee. The company has also announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also appointed Dr. Gunmala Suri as an Additional Director and reconstituted the Audit Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange about the resignation of a Director/KMP/SMP.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange regarding the resignation of Mr. Surulichamy Senthilkumar as Non-Executive Non-Independent Director of the company, effective August 06, 2026.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has sold and surrendered leasehold rights in land situated in Jammu for a consideration of INR 9.60 crores and sold plant and machinery for INR 1.62 crores, both to a third-party buyer.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange about an update on the slump sale of its Empty Hard Gelatin Capsule business to Capnest Health Care Private Limited. The expected completion date of the slump sale has been extended to December 31, 2026.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange about change in the registered office of the Company, shifting from Shop No. 5, SL Enclave, Behind Sohi HP Gas Agency, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507 to Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, with effect from July 15, 2026.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing of accepted certificates on the stock exchanges.

Nectar Lifesciences Limited

Nectar Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.